Wire flash
LabTech: Semiconductor-related revenue only ~2%, warns of uncertainty after stock surge
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
LabTech (688056.SH) issued a stock exchange announcement on September 24, stating that its share price had risen by an accumulated 30% over three consecutive trading days, triggering an abnormal stock movement disclosure. The company conducted an internal review and confirmed that its production and operations are normal, with no undisclosed material information. LabTech attributed the price surge to recent widespread market attention on the semiconductor and scientific instrument sectors, combined with the fact that some of its products can be applied in the semiconductor industry. However, the company disclosed that its inductively coupled plasma mass spectrometry series products and related consumables generated only about 2% of total revenue from the semiconductor field over the past year and most recent quarter. LabTech warned that semiconductor customer certification cycles are long, entry barriers are high, and domestic instruments still face challenges in user acceptance and brand recognition. The company cautioned that the pace of domestic substitution, subsequent order volumes, and profit contributions remain highly uncertain, urging investors not to equate industry trends with the company's actual earnings outlook.
Source report
Beijing, September 24 (Blue Whale News) — LabTech Co., Ltd. (688056.SH) announced that its stock price has seen an accumulated deviation of 30% in closing price increases over three consecutive trading days, constituting abnormal stock trading volatility.
Following an internal review, the company confirmed that its production and operations remain normal, and that there are no undisclosed material information items that should be disclosed.
According to the company's self-assessment, the recent surge in investor attention is attributable to widespread market interest in the semiconductor industry and scientific instrumentation sectors, combined with the fact that certain LabTech products can be applied in the semiconductor field.
However, LabTech emphasized that over the past year and the current reporting period, revenue from its inductively coupled plasma mass spectrometry (ICP-MS) series products and related consumables in the semiconductor sector accounted for only approximately 2% of total revenue — a very limited share.
The company further noted that the semiconductor industry involves long customer certification cycles and high entry barriers. Domestically produced instruments continue to face challenges in user acceptance and brand recognition. The pace and full realization of the domestic substitution process will require significant time and accumulation.
LabTech issued a郑重 warning that the progress of related business development, subsequent order volumes, and profit contributions all remain highly uncertain. The company urged investors to view current market trends rationally and not equate industry热点 with the company's own performance expectations.
Source
蓝鲸财经Neutral / independent
Part of this Story
LabTech stock surges 30% in 3 days; firm warns semiconductor revenue is only 2%